Technology Analysis & Strategic Management, Volume 29, Issue 3 (2017)

Browse this journal
Sample our Economics, Finance,Business & Industry journals, sign in here to start your access, latest two full volumes FREE to you for 14 days

Technology Analysis & Strategic Management, Volume 29, Issue 3 (2017)

See all volumes and issues
Vol 36, 2024 Vol 35, 2023 Vol 34, 2022 Vol 33, 2021 Vol 32, 2020 Vol 31, 2019 Vol 30, 2018 Volume 29, 2017 Vol 28, 2016 Vol 27, 2015 Vol 26, 2014 Vol 25, 2013 Vol 24, 2012 Vol 23, 2011 Vol 22, 2010 Vol 21, 2009 Vol 20, 2008 Vol 19, 2007 Vol 18, 2006 Vol 17, 2005 Vol 16, 2004 Vol 15, 2003 Vol 14, 2002 Vol 13, 2001 Vol 12, 2000 Vol 11, 1999 Vol 10, 1998 Vol 9, 1997 Vol 8, 1996 Vol 7, 1995 Vol 6, 1994 Vol 5, 1993 Vol 4, 1992 Vol 3, 1991 Vol 2, 1990 Vol 1, 1989
Download citations Download PDFs Download issue

Biosimilar: Capabilities, Regulations and Affordable Healthcare

Editorial

Editorial
The special issue of the journal Technology Analysis & Strategic Management on biosimilar: capabilities, regulations and affordable healthcare
Dinar Kale & Jorge Niosi
Pages: 247-250
Published online: 13 Feb 2017
First Page PreviewforThe special issue of the journal Technology Analysis & Strategic Management on biosimilar: capabilities, regulations and affordable healthcare | Full Text | PDF (313.3 KB)
  • 1306 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Articles

Article
Imitation and innovation new biologics, biosimilars and biobetters
Jorge Niosi
Pages: 251-262
Published online: 28 Nov 2016
AbstractforImitation and innovation new biologics, biosimilars and biobetters | Full Text | References | PDF (907.3 KB)
  • 592 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Translating European regulatory approval into healthcare uptake for biosimilars: the second translational gap
Virginia Acha & Jorge Mestre-Ferrandiz
Pages: 263-275
Published online: 13 Feb 2017
AbstractforTranslating European regulatory approval into healthcare uptake for biosimilars: the second translational gap | Full Text | References | PDF (1.3 MB)
  • 1943 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Biosimilars in Germany: the emergence of a new industry in the light of the varieties of capitalism approach
Andreas Pyka, Tobias Buchmann & Ben Vermeulen
Pages: 276-289
Published online: 08 Dec 2016
AbstractforBiosimilars in Germany: the emergence of a new industry in the light of the varieties of capitalism approach | Full Text | References | PDF (1,000.7 KB)
  • 379 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Biosimilars in North America
Jorge Niosi
Pages: 290-299
Published online: 21 Nov 2016
AbstractforBiosimilars in North America | Full Text | References | PDF (733.4 KB)
  • 222 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Heterogeneity in learning processes and the evolution of dynamic managerial capabilities as a response of emergence of biosimilar market: evidence from the Indian pharmaceutical industry
Dinar Kale & Farah Huzair
Pages: 300-312
Published online: 12 Jan 2017
AbstractforHeterogeneity in learning processes and the evolution of dynamic managerial capabilities as a response of emergence of biosimilar market: evidence from the Indian pharmaceutical industry | Full Text | References | PDF (1.4 MB)
  • 417 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Using the functional analysis to understand the emergence of biomaterials within an existing biotechnology system: observations from a case study in Turkey
Dilek Cetindamar & Annika Rickne
Pages: 313-324
Published online: 28 Nov 2016
AbstractforUsing the functional analysis to understand the emergence of biomaterials within an existing biotechnology system: observations from a case study in Turkey | Full Text | References | PDF (835.8 KB)
  • 212 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Middle-ground players in dynamic imitative markets: global entry strategies of Korean firms in the biosimilars market
SungWoong Hwang
Pages: 325-338
Published online: 13 Oct 2016
AbstractforMiddle-ground players in dynamic imitative markets: global entry strategies of Korean firms in the biosimilars market | Full Text | References | PDF (1.1 MB)
  • 477 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles